04:21 PM EDT, 09/12/2024 (MT Newswires) -- Paul J Diaz, Director, President and CEO, on September 11, 2024, sold 15,000 shares in Myriad Genetics ( MYGN ) for $400,800. Following the Form 4 filing with the SEC, Diaz has control over a total of 977,378 shares of the company, with 977,378 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/899923/000162828024040232/xslF345X05/wk-form4_1726171896.xml